| Date | Title | Description | Source |
| 20.12.2023 | GSK Expands Again in Cancer, Paying Hansoh $185M for Another... | GSK’s cancer drug pipeline is getting bigger with the addition of another antibody drug conjugate, o... | medcitynew... |
| 19.01.2022 | Unilever backs down on raising £50bn bid for GSK consumer he... | Unilever has ruled out raising its £50bn bid for GlaxoSmithKline’s consumer health arm after the pha... | cityam.com... |
| 27.10.2021 | GSK brings Johns Hopkins prof and Blade co-founder on board... | GlaxoSmithKline CEO Emma Walmsley is adding another scientist to the company’s board. Ea... | endpts.com... |
| 13.10.2021 | GSK tangoes with private equity players to explore $54... | The spinout of GlaxoSmithKline’s consumer health unit could reportedly take the form of a $5... | endpts.com... |
| 20.09.2021 | GSK - ANNOUNCES £50M INVESTMENT IN RENEWABLE ENERGY AND CARB... | GSK - ANNOUNCES £50M INVESTMENT IN RENEWABLE ENERGY AND CARBON REDUCTION | marketscre... |
| 20.09.2021 | GlaxoSmithKline : GSK Announces £50m Investment In Renewable... | Sept 20 (Reuters) - GlaxoSmithKline PLC:
* PRESS RELEASE: GSK ANNOUNCES MAJOR RENEWABLE ENERGY INVE... | marketscre... |
| 06.08.2021 | A Wharton MBA grad and a former GSK exec’s healthcare startu... | The Mumbai-based startup was founded in August last year.
Shashwata has an MBA from Wharton and stud... | businessin... |
| 07.04.2020 | Pharma giant GSK takes $250m stake in firm to develop corona... | Pharmaceuticals giant Glaxosmithkline (GSK) has taken a $250m (£202.7m) stake in an American biotech... | cityam.com... |
| 03.12.2018 | Term Sheet — Monday, December 3 | THE CRYSTAL BALL
Good morning, Term Sheet readers. Sending this from a plane, so the deals section ... | fortune.co... |
| 03.12.2018 | GlaxoSmithKline to buy cancer-focused Tesaro for $5.1 billio... | Tesaro’s only marketed product is Zejula (niraparib), a PARP inhibitor approved for the maintenance ... | medcitynew... |
| 13.08.2018 | Fresh from GSK deal, Orchard raises $150M for multifront lat... | Orchard Therapeutics has raised $150 million (€132 million) to advance three gene therapies toward a... | fiercebiot... |
| 13.08.2018 | Fresh from hauling in GSK’s budget-priced gene therapy g... | Just a few months ago Orchard Therapeutics was handed the opportunity of taking over Glax... | endpts.com... |
| 27.04.2017 | Tesaro gets its PD-1 registration study started, huntin... | → Tesaro $TSRO has launched a registration study for its PD-1 drug TSR-042, which was developed... | endpts.com... |
| 16.11.2016 | GSK vet Jason Gardner takes the helm of Magenta, emergi... | Jason Gardner, Magenta CEO. Jen Randall Photography.
Jason Gardner returned to his old s... | endpts.com... |
| 27.10.2016 | GSK dumps a late-stage HIV drug; MIT offers support for te... | Andrew Witty, GSK
GlaxoSmithKline didn’t just kill losmapimod on Wednesday. The pharma gia... | endpts.com... |
| 21.10.2016 | India: Entrepreneur GSK Velu’s eye care chain to raise $30m ... | Premium
Maxivision Super Specialty Eye Hospitals, a Chennai-based eyecare chain owned by G.S.K. Vel... | dealstreet... |
| 30.06.2016 | New ovarian cancer drugs raise hope — but not for all | Promising new therapies are springing up to treat ovarian cancer, long one of the most deadly and ha... | statnews.c... |
| 31.01.2014 | East Coast Biotech Roundup: Dicerna, J&J, Neurophage, &a... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
[Updated, 8:44 am ET] Local biotec... | xconomy.co... |
| 08.08.2013 | GSK launches $50M fund to invest in pioneering bioelectronic... | It is looking to invest in three different sets of companies:
New start-up companies that aim to pur... | medcitynew... |
| 06.03.2013 | Tesaro pockets $91M in big financing as major cancer trials ... | With key results expected from its lead cancer program this year, the cancer drug specialist Tesaro ... | fiercebiot... |
| 28.08.2012 | Rock Health boosts startup funding to $100,000, adds Kleiner... | In an interview with TechCrunch, Rock Health CEO Halle Tecco said that the increase in funding refle... | medcitynew... |
| 08.06.2012 | Less than 1% of HGSI shares tendered for sale; GSK extends $... | While GSK is trying to secure a sale within this month, HGS has a different timeline in mind. The co... | medcitynew... |
| 21.06.2011 | TESARO Secures $101M in Series B Financing | TESARO, Inc., a Waltham, Massachusetts-based oncology-focused biopharmaceutical company, has secured... | finsmes.co... |
| 26.05.2010 | Tesaro Secures $60M in Start up Funding | TESARO, Inc., a Boston, Massachusetts-based oncology-focused biopharmaceutical company focused on de... | finsmes.co... |
| - | GSK gets pneumococcal vaccine contender with $2.1B Affinivax... | Pneumococcal vaccines sales are dominated by Pfizer, and to a lesser extent, Merck, each company ste... | medcitynew... |
| - | GlaxoSmithKline to buy cancer-focused Tesaro for $5.1 billio... | British drugmaker GlaxoSmithKline plans to purchase a US-based manufacturer of drugs for cancers, th... | medcitynew... |
| - | Rock Health boosts startup funding to $100,000, adds Kleiner... | Bam! Rock Health investors up seed funding for startups to $100K shar.es/7JiW3
— Rock Health (@Rock... | medcitynew... |
| - | Less than 1% of HGSI shares tendered for sale; GSK extends $... | GlaxoSmithKline‘s (NYSE:GSK) $2.6 billion offer to buy Human Genome Sciences (NASDAQ:HGSI) has entic... | medcitynew... |
